Medtronic secures FDA milestones for its MiniMed 780G system, expanding use to type 2 diabetes and enabling sensor integration.
Vous n'êtes pas connecté
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
Medtronic secures FDA milestones for its MiniMed 780G system, expanding use to type 2 diabetes and enabling sensor integration.
Abbott wins CE Mark in Europe for expanded Navitor use, boosting its Structural Heart business and lifting ABT stock.
MetLife enhances its Critical Illness Insurance with a new Cancer Support benefit, offering enhanced care and guidance from Private Health Management...
MetLife enhances its Critical Illness Insurance with a new Cancer Support benefit, offering enhanced care and guidance from Private Health Management...
PATH Q2 performance is likely to benefit from subscription revenue growth and strong tech partnerships, though license sales remain a key drag.
Abbott (ABT) concluded the recent trading session at $129.36, signifying a -1.96% move from its prior day's close.
Abbott (ABT) concluded the recent trading session at $129.36, signifying a -1.96% move from its prior day's close.
Last week, prominent Vancouver-based real estate developer Westbank welcomed Darren Tangen as its new President, the company tells STOREYS.Tangen...
Last week, prominent Vancouver-based real estate developer Westbank welcomed Darren Tangen as its new President, the company tells STOREYS.Tangen...
OpenAI announced that it will introduce new parental monitoring features for its AI chatbot, ChatGPT, in response to growing concerns over child...